Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-22T00:06:47.542Z Has data issue: false hasContentIssue false

17 - Engineering of Non-CDR Loops in Immunoglobulin Domains

from PART VI - NOVEL ANTIBODY FORMATS

Published online by Cambridge University Press:  15 December 2009

Melvyn Little
Affiliation:
Affimed Therapeutics AG
Get access

Summary

The immune system creates binding sites of high specificity and affinity in the variable domains of antibodies by generating sequence and consequently structural diversity in the complementarity-determining region (CDR) loops, which are located at the N-terminal ends of these domains. Sequence variations in the CDR loops of an antibody generally do not have a significant influence on the overall structure of the variable domain that carries them. This feature of variable domains is actually observed in a more general sense in immunoglobulin-like domains, which are known to have a similar general shape in the core beta-barrel and high structural variability in the loops. Furthermore, overall sequence similarity of domains with an immunoglobulin fold is mainly below 25%, while their structural similarity is high, with a root mean square (rms) deviation of Cα atoms always below 3.9 Å (Halaby et al., 1999).

We therefore set out to explore whether this inherent stability and conservation of the immunoglobulin fold allows loops of immunoglobulin domains other than the CDR loops to accommodate sequence variation without negatively impacting the overall structure and stability of the protein. As shown in Figure 17.1, the candidate loops of an IgG1 for this kind of engineering are manifold, including the N- and C-terminal loops of the constant domains as well as C-terminal loops of the variable domains.

In the examples described in this chapter, we engineered the AB and the EF loops of the third constant domain (CH3) of human IgG1 by randomizing a number of residues and also by inserting random sequences in the loops, thereby generating new binding sites.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brown, WR, Newcomb, RW, Ishizaka, K. Proteolytic degradation of exocrine and serum immunoglobulins. J Clin Invest. 1970 Jul;49(7):1374–80.CrossRefGoogle ScholarPubMed
Clackson, T (ed). Phage display, a practical approach. Oxford Univ. Press, 2004 (Practical approach series; 266).
Coley, AM, Gupta, A, Murphy, VJ, Bai, T, Kim, H, Anders, RF, Foley, M, Batchelor, AH. Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. PLoS Pathog. 2007 Sep 7;3(9):1308–19.Google ScholarPubMed
Datta-Mannan, A, Witcher, DR, Tang, Y, Watkins, J, Jiang, W, Wroblewski, VJ. Humanized IgG1 variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates. Drug Metab Dispos. 2007 Jan;35(1):86–94.CrossRefGoogle ScholarPubMed
Halaby, DM, Poupon, A, Mornon, J. The immunoglobulin fold family: sequence analysis and 3D structure comparisons. Protein Eng. 1999 Jul;12(7):563–71.CrossRefGoogle ScholarPubMed
Hoogenboom, HR, Griffiths, AD, Johnson, KS, Chiswell, DJ, Hudson, P, Winter, G. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 1991 Aug 11;19(15):4133–7.CrossRefGoogle ScholarPubMed
Koivunen, E, Gay, DA, Ruoslahti, E. Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. J Biol Chem. 1993 Sep 25;268(27):20205–10.Google Scholar
Landau, M, Mayrose, I, Rosenberg, Y, Glaser, F, Martz, E, Pupko, T, Ben-Tal, N. ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W299–302.CrossRefGoogle ScholarPubMed
Perosa, F, Favoino, E, Caragnano, MA, Dammacco, F. CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases. Ann N Y Acad Sci. 2005 Jun;1051:672–83.CrossRefGoogle ScholarPubMed
Raghavan, M, Bonagura, VR, Morrison, SL, Bjorkman, PJ. Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry. 1995 Nov 14;34(45):14649–57.CrossRefGoogle Scholar
Ruiz, M, Lefranc, MP. IMGT gene identification and Colliers de Perles of human immunoglobulins with known 3D structures. Immunogenetics. 2002 Feb;53(10–11):857–83.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×